How Tregs Contribute to Heart Transplant Rejection
Author Information
Author(s): Warunek Jordan J.P., Fan Lu, Zhang Xue, Wang Sihua, Sanders Steven M., Li Tengfang, Mathews Lisa R., Dwyer Gaelen K., Wood-Trageser Michelle A., Traczek Stephanie, Lesniak Andrew, Baron Kassandra, Spencer Hailey, Bou Saba Johnny, León Colón Emmanuel, Tabib Tracy, Lafyatis Robert, Ross Mark A., Demetris Anthony J., Watkins Simon C., Webber Steven A., Abou-Daya Khodor I., Turnquist Hēth R., Thomas E. Starzl
Primary Institution: University of Pittsburgh School of Medicine
Hypothesis
Dysregulated Treg repair responses lead to chronic rejection after heart transplantation.
Conclusion
The study identifies how a dysregulated repair response involving interactions between IL-33+ fibroblasts in the allograft and recipient Tregs contributes to chronic rejection.
Supporting Evidence
- IL-33 was found to contribute positively to the generation of reparative-type macrophages.
- Treg-derived Areg supports vascular occlusion and perivascular fibrosis.
- Chronic rejection is a leading cause of death after the first post-transplantation year.
- Recipient repair responses become dysregulated in the allograft.
- Tregs can contribute to chronic rejection through dysregulated repair mechanisms.
- IL-33 acts as a reparative-type DAMP that triggers tissue repair pathways.
Takeaway
This study shows that Tregs, which usually help repair tissues, can actually make things worse after a heart transplant by causing scarring and damage.
Methodology
Single-cell RNA sequencing was used to analyze immune cells in heart transplants.
Limitations
The study primarily used mouse models, which may not fully replicate human responses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website